Company Presentation • 06 Nov 2024 21:30
Company Presentation • 08 Aug 2024 20:00
Company Presentation • 28 May 2024 20:30
Company Presentation • 09 May 2024 20:00
Company Presentation • 15 Feb 2024 21:00
ENTITY
Royalty Pharma (RPRX US)
Royalty Pharma (RPRX US)
9
Analysis
Health Care • United States
Royalty Pharma plc acquires biopharmaceutical royalties. The Company funds innovation directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators.
more
x